InvestorsHub Logo
Followers 21
Posts 580
Boards Moderated 0
Alias Born 01/21/2011

Re: diamond482 post# 19914

Friday, 01/16/2015 3:41:12 PM

Friday, January 16, 2015 3:41:12 PM

Post# of 140468
Titan is under capitalized to get to market with SPORT, but a lot can and will happen between now and then. I'm in the camp that the PPS will be supported by management and Sherry Bertner. Not only through keeping the market more informed and her institutional contacts, but also by Titan forming strategic partnerships with others in the industry for development.

I actually think the next grow catalyst will be when the design freeze occurs ("Design and test of feasibility prototype complete" Q1 2015). The freeze signifies when detailed design phase has been completed and at which point the final version of the technical drawings are signed off and released to production.

So, when the design is frozen the product can be manufactured - there will be no more changes to the design of the machine at that point (unless it's changes like safety issues or problem corrections). Further cost reductions that are discovered will have to be implemented in the next product generation.

I think that the significance of that shouldn't be understated, and the market will react if/when they accomplish this milestone on time.

You commented on how management can be trusted, and I can't argue with that, when twice now they've changed course - you'll have to make a judgement call on that. Our friend CUIN is not happy and has mentioned that next time there is share appreciation he's going to look for an exit. It's unfortunate, however he is not alone in feeling this way, all longs must to some degree, and I respectfully understand their decisions.

However, when the design is frozen the next stages are all in Ximedica and Dr. Fowler's hands, and I believe that they are both extremely capable.

The next milestone will be engineering completion Q4 2015, and Titan can start showcasing its machines in participant hospitals for clinical trials. Word will spread quickly if it's the machine that we all believe it will be, so I think that a lot will happen before human clinical trials. Yes, money is an issue, but there will be opportunities to support PPS and get the warrants exercised if management stays the course here and meets milestones on time or early.